Company Search:
Advanced Search
Sponsored Links
NexgenRx Inc. Company Snapshot
NexgenRx Inc. operates in the Hospital and medical service plans sector. In addition to historical fundamental analyses, the complete report available to purchase compares NexgenRx Inc. with three other insurance companies in North America: Emergent Capital Inc of the United States (2016 sales of $1.12 million of which 100% was Life Finance), Jacobs Financial Group, Inc. of the United States ($1.34 million ), and Westaim Corporation (The) (3.56 million Canadian Dollars [US$2.75 million] ).

Sales Analysis. NexgenRx Inc. reported sales of C$5.75 million (US$4.44 million) for the year ending December of 2016. This represents an increase of 22.6% versus 2015, when the company's sales were C$4.69 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
NexgenRx Inc.
  Stock Performance Chart for NexgenRx Inc.
  Stock Data: Recent Stock Performance:
  Current Price (3/15/2018): .24
(Figures in Canadian Dollars)
1 Week -2.0%   13 Weeks 4.3%  
4 Weeks 0.0%   52 Weeks -4.0%  
NexgenRx Inc. Key Data:
  Ticker: NXG Country: Canada
  Exchanges: VEN Major Industry: Health Care Equipment & Services
    Sub Industry: Hospital & Medical Service Plans
  2016 Sales 5,754,736
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 16,228,612
  Fiscal Yr Ends: December Shares Outstanding: 67,619,216
  Share Type: Closely Held Shares: 21,833,560
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.